Financials
- Market Capitalization 4.6 M
- Employee 7
- Founded 2016
- CEO N/A
- Website www.alzamend.com
- Headquarter Delaware, United States
- FIGI BBG00ZMXG7M8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.52
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4980 | MBIO Mustang Bio, Inc. - Common Stock | 0.66 USD | 0.00% | -2.94% | -9.59% | -23.96% | 4.78 M USD | ||
| 4981 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 0.37 USD | +5.71% | +2.78% | +8.82% | -77.02% | 4.74 M USD | ||
| 4989 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 0.10 USD | -9.09% | -16.67% | -16.67% | -98.36% | 4.49 M USD | ||
| 4993 | FBLG FibroBiologics, Inc. - Common Stock | 0.85 USD | -1.16% | +3.66% | -7.61% | +30.77% | 4.43 M USD |